Google has announced a partnership with medical technology company Abbott, which is allowing the tech giant's continuous glucose monitor (CGM) data to be used in its Google Health app. The new integration is expected to revolutionize diabetes management by providing users with a more comprehensive understanding of their health trends.
Under the multi-year agreement, data from Abbott's Lingo CGM will be seamlessly integrated into the Google Health app, allowing users to view glucose trends alongside other personal health metrics. This move comes as part of Google's efforts to expand its AI-powered health coaching capabilities, which already utilize machine learning algorithms to analyze user data.
By combining Abbott's CGM data with Google's AI-driven health coaching tools, users will be able to better understand their diabetes management and make informed decisions about their care. The integration is set to launch in the coming months, although no specific release date has been announced. This partnership represents a significant step forward for Google's efforts to develop more personalized and effective healthcare solutions using artificial intelligence.